4461 related articles for article (PubMed ID: 19325461)
1. Glucose control in the intensive care unit.
Fahy BG; Sheehy AM; Coursin DB
Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
[TBL] [Abstract][Full Text] [Related]
2. [Glycaemia control in critically ill patients is justified and effective].
Rybka J
Vnitr Lek; 2010 Sep; 56(9 Suppl):977-87. PubMed ID: 21137171
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic aspects and analytical problems of glycemia monitoring in intensive care unit patients].
Solnica B
Przegl Lek; 2006; 63(9):792-6. PubMed ID: 17479872
[TBL] [Abstract][Full Text] [Related]
4. Therapy insight: the effect of tight glycemic control in acute illness.
Langouche L; Vanhorebeek I; Van den Berghe G
Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):270-8. PubMed ID: 17315035
[TBL] [Abstract][Full Text] [Related]
5. Intensive insulin therapy for critically ill patients.
Lewis KS; Kane-Gill SL; Bobek MB; Dasta JF
Ann Pharmacother; 2004; 38(7-8):1243-51. PubMed ID: 15187219
[TBL] [Abstract][Full Text] [Related]
6. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
Van den Berghe G; Wouters PJ; Bouillon R; Weekers F; Verwaest C; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P
Crit Care Med; 2003 Feb; 31(2):359-66. PubMed ID: 12576937
[TBL] [Abstract][Full Text] [Related]
7. Insulin treatment in intensive care patients.
Derde S; Vanhorebeek I; Van den Berghe G
Horm Res; 2009 Jan; 71(1):2-11. PubMed ID: 19039231
[TBL] [Abstract][Full Text] [Related]
8. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality.
Meyfroidt G; Keenan DM; Wang X; Wouters PJ; Veldhuis JD; Van den Berghe G
Crit Care Med; 2010 Apr; 38(4):1021-9. PubMed ID: 20124887
[TBL] [Abstract][Full Text] [Related]
9. Addressing hyperglycemia from hospital admission to discharge.
Moghissi ES
Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
[TBL] [Abstract][Full Text] [Related]
10. Alterations in glucose homeostasis in the pediatric intensive care unit: Hyperglycemia and glucose variability are associated with increased mortality and morbidity.
Hirshberg E; Larsen G; Van Duker H
Pediatr Crit Care Med; 2008 Jul; 9(4):361-6. PubMed ID: 18496414
[TBL] [Abstract][Full Text] [Related]
11. Lowering of glucose in critical care: a randomized pilot trial.
McMullin J; Brozek J; McDonald E; Clarke F; Jaeschke R; Heels-Ansdell D; Leppert R; Foss A; Cook D
J Crit Care; 2007 Jun; 22(2):112-8; discussion 118-9. PubMed ID: 17548021
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit.
Clayton SB; Mazur JE; Condren S; Hermayer KL; Strange C
Crit Care Med; 2006 Dec; 34(12):2974-8. PubMed ID: 17075371
[TBL] [Abstract][Full Text] [Related]
13. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients.
Chant C; Wilson G; Friedrich JO
Pharmacotherapy; 2005 Mar; 25(3):352-9. PubMed ID: 15843282
[TBL] [Abstract][Full Text] [Related]
14. Blood glucose concentration and outcome of critical illness: the impact of diabetes.
Egi M; Bellomo R; Stachowski E; French CJ; Hart GK; Hegarty C; Bailey M
Crit Care Med; 2008 Aug; 36(8):2249-55. PubMed ID: 18664780
[TBL] [Abstract][Full Text] [Related]
15. Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital.
Krinsley JS
Semin Thorac Cardiovasc Surg; 2006; 18(4):317-25. PubMed ID: 17395028
[TBL] [Abstract][Full Text] [Related]
16. An insulin infusion protocol in critically ill cardiothoracic surgery patients.
Zimmerman CR; Mlynarek ME; Jordan JA; Rajda CA; Horst HM
Ann Pharmacother; 2004; 38(7-8):1123-9. PubMed ID: 15150382
[TBL] [Abstract][Full Text] [Related]
17. A protocolized approach to identify and manage hyperglycemia in a pediatric critical care unit.
Preissig CM; Hansen I; Roerig PL; Rigby MR
Pediatr Crit Care Med; 2008 Nov; 9(6):581-8. PubMed ID: 18838924
[TBL] [Abstract][Full Text] [Related]
18. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring.
De Block C; Manuel-Y-Keenoy B; Van Gaal L; Rogiers P
Diabetes Care; 2006 Aug; 29(8):1750-6. PubMed ID: 16873775
[TBL] [Abstract][Full Text] [Related]
19. A physiological Intensive Control Insulin-Nutrition-Glucose (ICING) model validated in critically ill patients.
Lin J; Razak NN; Pretty CG; Le Compte A; Docherty P; Parente JD; Shaw GM; Hann CE; Geoffrey Chase J
Comput Methods Programs Biomed; 2011 May; 102(2):192-205. PubMed ID: 21288592
[TBL] [Abstract][Full Text] [Related]
20. Endocrine and metabolic disturbances in critical illness: relation to mechanisms of organ dysfunction and adverse outcome.
Langouche L; Mesotten D; Vanhorebeek I
Verh K Acad Geneeskd Belg; 2010; 72(3-4):149-63. PubMed ID: 21067067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
